Malignant neoplasm (controls excluding all cancers)

C3_CANCER_EXALLC

No definition available.

Endpoint definition

FinnGen phenotype data

individuals

diagram downward connector

Apply sex-specific rule None

diagram downward connector

Check conditions None

diagram downward connector
diagram bullet

Check pre-conditions, main-only, mode, registry filters

KELA reimbursements: KELA codes 115|116|130

1 out of 7 registries used, show all original rules.

-

diagram downward connector

Check minimum number of events None

-

diagram downward connector
diagram bullet diagram downward connector

Remove individuals based on genotype QC

87530

diagram downward connector
C3_CANCER_EXALLC

Control definitions

Control exclude C3_CANCER, C3_CANCER_WIDE

Extra metadata

Level in the ICD hierarchy 1
First used in FinnGen datafreeze DF9

Summary Statistics

Key figures

All Female Male
Number of individuals 87530 42157 45373
Unadjusted prevalence (%) 21.25 18.31 24.97
Mean age at first event (years) 63.05 59.60 66.25

Mortality

Follow-up Absolute risk HR [95% CI] p N
1998–2019 0.09 4.59 [4.24, 4.96] <1e-100 23240
15 years 0.01 2.08 [1.92, 2.27] 5.3e-66 6613
5 years 0.01 6.57 [6.15, 7.02] <1e-100 7147
1 year 0.01 30.84 [27.93, 34.07] <1e-100 7331

Age distribution of first events

Year distribution of first events

Cumulative Incidence

Correlations

Index endpoint: C3_CANCER_EXALLC – Malignant neoplasm (controls excluding all cancers)
GWS hits: 54

Survival analyses between endpoints

Plot

before Malignant neoplasm (controls excluding all cancers)
after Malignant neoplasm (controls excluding all cancers)

loading spinner Loading survival analyses plot

Drugs most likely to be purchased after Malignant neoplasm (controls excluding all cancers)

Endpoint not on priority list, no data to show.